Related Experiment Videos

Biological markers and the cholinergic hypothesis in Alzheimer's disease

¹Department of Pharmacology, Uppsala University, Sweden.

Acta Neurologica Scandinavica. Supplementum

|January 1, 1992

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers.

European journal of nuclear medicine and molecular imaging·2021

2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework.

European journal of nuclear medicine and molecular imaging·2021

Clinical validity of increased cortical uptake of [18F]flortaucipir on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase biomarker development framework.

European journal of nuclear medicine and molecular imaging·2021

Regional binding of tau and amyloid PET tracers in Down syndrome autopsy brain tissue.

Molecular neurodegeneration·2020

Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer's disease dementia.

Molecular psychiatry·2017

Regional [(3)H]acetylcholine and [(3)H]nicotine binding in developing mouse brain.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience·2014

See all related articles